CoorsTek Medical recently announced a five-year, multi-million-dollar capital investment program to support the growing worldwide demand for its ceramic hip replacement components and turnkey hip arthroplasty solutions. The investment funds a twenty-fold production expansion of these products as major medical device manufacturers adopt the company’s CeraSurf® medical-grade ceramics.

The CoorsTek Medical CeraSurf alumina matrix composite is reportedly both CE-compliant and substantially equivalent to the latest-generation material used in ceramic hip implants today. Since 2011, more than 7,000 CeraSurf hip balls and acetabular liners have been sold for distribution across key global markets. CoorsTek Medical provides specialized OEM medical device solutions designed around durable, biocompatible ceramic technology, delivering more than one million components annually to the world’s leading medical device manufacturers.

“As we engage medical innovators and key opinion leaders globally, they are applying the unique, high-performance benefits of our ceramic materials to improve the longevity and lifestyle for more patients each year,” said Jonathan Coors, CEO of CoorsTek Medical. “Our valued partners deserve a choice and will be successful with a trusted partner who embraces today’s dynamic healthcare economy. This investment demonstrates the CoorsTek Medical commitment to being that partner of choice for implant-grade ceramic materials that make lives measurably better.”

 For more information, email ceramics@coorstekmedical.com or visit www.coorstekmedical.com.